Approvals/CIMA-AEMPS/VANDRAL RETARD 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA

Approved

STANDARD

VANDRAL RETARD 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA

Upjohn Eesv🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b4822a728511af02
Drug Cima Aemps Name: VANDRAL RETARD 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA
Register Number: 123043IP
Holder Company Name: Upjohn Eesv
Marketing Company Name: Difarmed S.L.U.
Holder Company Detail Path: /organization/upjohn-eesv
Authorization Date: 2024-11-13
Dosage Form: CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose: 150 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Upjohn Eesv
Company Detail Path: /organization/upjohn-eesv

VENLAFAXINA HIDROCLORURO

169,7 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 13, 2024

Approval ID

b4822a728511af02

Type

Standard